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Adenovirus uncoating is a stepwise process which
culminates in the release of the viral DNA into the
nucleus through the nuclear pore complexes and disso-
ciation of the capsid. Using quantitative biochemical,
immunochemical and morphological methods, we dem-
onstrate that inhibitors of the cysteine protease, L3/
p23, located inside the capsid block the degradation of
the capsid-stabilizing protein VI, and prevent virus
uncoating at the nuclear membrane. There was no
effect on virus internalization, fiber shedding and virus
binding to the nuclear envelope. The viral enzyme
(dormant in the extracellular virus) was activated by
two separate signals, neither of which was sufficient
alone; virus interaction with the integrin receptor
(inhibited with RGD peptides) and re-entry of the virus
particle into a reducing environment in the endosome
or the cytosol. Incorrectly assembled mutant viruses
that lack the functional protease (tsl) failed at releasing
fibers and penetrating into the cytosol. The results
indicated that L3/p23 is needed not only to assemble
an entry-competent virus but also to disassemble the
incoming virus.
Keywords: adenovirus/endocytosis/integrins/nuclear trans-
port/protease
Introduction
Entry of adenovirus into a host cell is a complex, stepwise
process. First, the virus attaches with high affinity to an
as yet unidentified cell surface receptor via the globular
head domains of the protruding viral fibers (Philipson
et al., 1968; Louis et al., 1994; Xia et al., 1995). A
secondary receptor, the fibronectin binding integrin, then
associates with the penton base protein, and as a result
the virus is endocytosed via coated pits and coated vesicles
(Varga et al., 1991; Bai et al., 1993; Belin and Boulanger,
1993; Wickham et al., 1993). Penetration of the viral
particles from endosomes into the cytosol occurs by acid-
triggered lysis of the endosomal membrane, a reaction
most likely mediated by the integrins and the penton base
protein (Pastan et al., 1986; Wickham et al., 1994). Having
thus entered the cytosol, the viral particles are next
transported through the cytoplasm to the nuclear mem-
brane, and attach to the cytosolic face of the nuclear
pore complexes (Lonberg-Holm and Philipson, 1969;
Chardonnet and Dales, 1970; Dales and Chardonnet, 1973;
Greber et al., 1993). The DNA is released through the
pore, and the viral capsid dissociates (Horwitz, 1990).
At different stages during passage from the cell surface
to the nuclear pore, several proteins are detached from
the virion and some of them are even degraded (Greber
et al., 1993). The first to be lost are the fibers which
dissociate already during endocytic uptake. Some of the
penton base complexes are also removed during the early
stages of entry, followed by proteins IlIa, VIII and IX,
which detach from the surface of the virion in the cytosol
(Greber et al., 1994). The degradation of protein VI, a
protein located inside the capsid, underneath the peripen-
tonal hexons, starts already in endocytic vacuoles and is
completed when the virus reaches the nuclear envelope
(Greber et al., 1993). The stepwise dismantling most likely
results in the weakening of the capsid structure so that
the DNA can be released efficiently at the nuclear pore,
and the remaining empty capsid dissociated.
Since protein VI is thought to link the DNA to the
inside of the capsid shell (Russell and Precious, 1982),
we have speculated that its elimination allows the release
of the viral DNA and is therefore a necessary part of the
uncoating process. How the protein gets degraded is not
known at present. However, since it is located inside the
capsid and, thus, is presumably poorly accessible to
cellular proteases, we have turned our attention to a viral
protease, the cysteine protease L3/p23, located in the
internal cavity at ~10 copies per virion (Anderson, 1990).
This protease, encoded in the late cassette L3 as a 23 kDa
polypeptide, is essential during the assembly of the virus
in the nucleus of infected cells (Weber, 1995). It is
responsible for cleaving six different capsid protein pre-
cursors during the assembly process, and is itself packaged
with the DNA into viral particles.
L3/p23 has eight cysteine residues, of which at least
one is needed for proteolytic activity (Weber, 1995). A
thiol-disulfide exchange mechanism is thought to provide
activation of the protease during virus assembly via a
disulfide-linked peptide dimer corresponding to the C-
terminal peptide of the protein VI precursor (Mangel et al.,
1993; Webster et al., 1993). When the activating peptide
is present, the activity of the enzyme is stimulated by
small concentrations of dithiothreitol (DTT) (Webster
et al., 1994). Enzymatic activity is destroyed by alkylating
agents such as N-ethylmaleimide (NEM), indicating that
free cysteines are involved in the catalytic mechanism
(Webster et al., 1989, 1994). A point mutation in the
protease gene, the tsl mutation, causes the enzyme to
misfold irreversibly and prevents its packaging into par-
ticles (Weber, 1976; Rancourt et al., 1995). The resulting
unprocessed particles do contain the DNA genome of the
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Fig. 1. Inhibition of cell infection with reduced/alkylated adenovirus.
Intracellular adenovirus or isolated adenovirus were treated with
reducing and alkylating agents as described in Materials and methods.
Infectivity was determined by taking the mean plaque number from
two 10-fold dilutions. 100% infectivity was obtained with untreated
virus. n indicates the number of independent experiments and bars
represent the standard deviations.
virus, but are unable to penetrate from endosomes, and
are obviously non-infectious (Miles et al., 1980; Hannan
et al., 1983; Cotten and Weber, 1995).
The experiments described here indicate that the L3/
p23 protease is not only needed for virus assembly but
also for uncoating during entry into the host cell. Active
protease packaged into viral particles during assembly in
the reducing cell nucleus is inactivated in the oxidizing
extracellular environment after virus release from the
infected cells. The protease is apparently reactivated during
virus entry into a reducing environment and by integrin
binding to penton base. As a result, the capsid-stabilizing
protein VI is degraded, the capsid disassembles at the
nuclear pore complex and the viral DNA can be released
into the nucleus.
Results
Sulfhydryl groups are important in adenovirus
infectivity
As a first test of whether L3/p23 might be needed during
virus entry, we added the protease activator DTT to
isolated virus and then inactivated the reduced protease
by treating virus with different alkylating and oxidizing
agents. These conditions have been reported to cause
inactivation of the isolated protease (Webster et al., 1989,
1994). As alkylating agents, we used NEM, iodoacetamide
(IAA) and (4',4')-dithiodipyridine (DTDP). A strong
sulfhydryl oxidant, diamide, was also used (Kosower and
Kosower, 1987).
These treatments were all found to lower infectivity 4-
to 5-fold, as measured by plaque assays 5 days after
infection (Figure 1). When infectivity was measured by
scoring cells that expressed the early protein ElA using
indirect immunofluorescence (Whyte et al., 1988), we
found that the DTT/NEM-treated virus infected only 3%
of the cells, while mock-treated control virus infected
60% (data not shown). The DTT/NEM-inactivated virus
could not be rescued by DTT reduction. In contrast,
the DTT/diamide-treated virus regained full infectivity.
Treatment of native virus with NEM, IAA, DTDP, diamide
or DTT alone had no effect on infectivity (Figure 1).
These results indicated that free thiols, either in the
viral protease, or in other structural proteins of the virus,
were critical for infectivity. Since both reduction and
alkylation were needed, these results suggested that the
critical cysteines were in the oxidized form in the isolated
viral particles, and had to be reduced to become a target
for alkylation.
Since the nucleoplasm in which the viruses assemble
provides a reducing environment, it seemed likely that the
cysteines in intranuclear, newly synthesized viral particles
were in the reduced form. When NEM was added to
infected cells shortly before the end of the infectious cycle
and the virus isolated, the infectivity was found to be 15-
to 20-fold lower than in mock-treated control (Figure 1).
In other words, no prior reduction with DTT was needed
to make the virus sensitive to alkylation. Apparently, the
critical cysteines become oxidized only when a virus is
released from the cell into the extracellular space. How-
ever, the oxidation event was not required to render
the virus infectious because adenovirus isolated under
reducing conditions from cells and applied to uninfected
cells in the continuing presence of 5 mM DTT was equally
infectious as control viruses (data not shown).
The data suggested that release of intracellular virus
from the reducing cellular milieu into the oxidizing extra-
cellular medium resulted in the formation of one or more
disulfide bonds in the viral proteins, which protected
critical sulfhydryl residue(s) against alkylation. However,
if these bonds were first artificially reduced, they could
be alkylated or re-oxidized in such a way that infectivity
was impaired.
The L3/p23 protease as a target of alkylation
To determine which viral proteins were alkylated, we
incubated DTT-reduced and non-reduced viruses with
[33H]NEM and then analyzed the proteins by SDS-PAGE
and autoradiography. A number of bands were labeled in
both preparations: the hexon, penton base, protein V and
two unidentified proteins with apparent mol. wts of 60
kDa and -22 kDa (Figure 2A, lanes 1 and 2). Protein VI,
which is known to be cysteine-free and migrate near the
32.5 kDa marker protein (Akusjarvi and Persson, 1981;
Greber et al., 1993), was not labeled, confirming the
specificity of labeling.
The most strongly labeled protein band was located
between proteins VI and VII and had an apparent mol.
wt of 28 kDa. It was labeled specifically in the reduced
virus, but not in native or reduced and alkylated DTT/
NEM virus. It migrated identically with recombinant L3/
p23 protease and with protease isolated from purified
adenovirus (Anderson, 1990). On Western blots, it could
be labeled with anti-L3/p23 protease antiserum (Figure
2B). We concluded that the band corresponded to the viral
protease, and that the protease was a major target for
alkylation after DTT reduction.
Interestingly, when extracted from reduced virus, a large
fraction of the protease migrated faster (Figure 2B, lane
7) than the protease from the non-reduced virus (Figure
2B, lane 6). Generally, reduced proteins migrate more
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Fig. 2. [3H]NEM labeling of adenovirus-associated L3/p23 protease.
Wild-type adenovirus was mock, DTT or DTT/NEM treated, dialyzed,
labeled with [3H]NEM for 20 min, quenched with cold NEM
(10 mM), TCA precipitated and equal quantities of protein were
separated by SDS-PAGE and analyzed by fluorography (A). Star and
ring symbols indicate unidentified proteins. In a parallel experiment,
purified wild-type adenovirus or tsl virus (grown at the restrictive
temperature of 39°C) was treated or not treated with DTT, NEM or
DTT/NEM, TCA precipitated, separated by SDS-PAGE, transferred to
nitrocellulose and probed with an anti-protease antiserum. Bound IgG
was detected by ECL with a goat anti-rabbit IgG coupled to
horseradish peroxidase (B). The identity of bands migrating at 31 kDa
(lane 6) and at 30 kDa (lanes 8 and 9) are unknown.
slowly than their oxidized counterparts. In fact, the
expected slower migration after reduction has been
described for the recombinant version of the L3/p23
protease in its chemically or air-oxidized versus reduced
forms (Tihanyi et al., 1993). The aberrant gel mobility of
the viral protease in our gels was therefore not likely to
be caused by intrachain disulfides. Instead, it was
consistent with the previously suggested presence of an
interchain disulfide that connects the protease to its
activator peptide, the C-terminal peptide from the protein
VI precursor (Mangel et al., 1993; Webster et al., 1993).
That the viral protease was covalently associated with a
peptide was supported by the observation that the defective
ts protease, which cannot generate the protein VI pre-
cursor peptide (Webster et al., 1993), did not show the
aberrant gel mobility after reduction (Figure 2B).
Internalization of tsl and DTTINEM-treated viruses
is normal
Next, we determined whether viruses that had been
inactivated by DTT/NEM treatment and viruses lacking
the protease (ts mutant virus) were affected in their early
interactions with host cells. To monitor the kinetics and
efficiency of binding and endocytic internalization, the
[35S]methionine-labeled viruses were allowed to bind to
KB cells in the cold. Endocytosis was initiated by adding
warm medium, whereafter surface viruses and endocytosed
viruses were assayed by determining trypsin accessibility
of the cell-associated viruses in the cold (Greber et al.,
1993). Degradation of the viral proteins was determined
using trichloroacetic acid (TCA) precipitation.
No abnormalities in binding to cells in the cold were
detected for either virus. For the DTT/NEM viruses, the
kinetics and the efficiencies of internalization were normal
and degradation was minimal (Figure 3). Similar results
were obtained with viruses treated with NEM or DTT
alone (data not shown). Internalization of all three virus
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Fig. 3. Internalization and degradation of wild-type and ts adenovirus
in the presence of inhibitors. (A) [35S]Methionine-labeled wild-type or
ts adenovirus was treated or not treated with DTT/NEM, dialyzed,
bound to KB cells in the cold (105 c.p.m. per dish), and endocytosed
in the presence or absence of GRGDSP peptides or RGES peptides
(irrelevant) for different times at 37°C. Cells were chilled in PBS and
treated with cold trypsin. Virus was TCA precipitated, and cleaved
(surface-bound) and uncleaved hexon (internalized) analyzed by
SDS-PAGE and fluorography. Internalized adenovirus was scored as
the percentage of trypsin-resistant hexon normalized to the 0 min time
point determined by densitometric scanning. (B) [35S]Methionine-
labeled wild-type or tsl adenovirus was bound in the cold to KB cells,
which were pre-treated or not with 20 ,ug/ml leupeptin (Sigma,
St Louis, MO) for 16 h, and endocytosed at 37'C for different times.
TCA-soluble and -insoluble radioactivity was determined by liquid
scintillation counting at non-quenching dilutions and data were
normalized to the 0 min time point. 100% was in the range 40 000-
50 000 c.p.m. for wild-type adenovirus (wt Ade) and 60 000-70 000
c.p.m. for tsl virus (B).
preparations was inhibited with RGD peptides, indicating
that it was integrin-mediated (Figure 3A) (Wickham et al.,
1993). Control peptides had no effect (Figure 3A).
When the entry kinetics of the ts 1 virus were determined,
an interesting abnormality was observed. Whereas the
initial uptake looked normal (Figure 3A), the amount of
cell-associated virus began to drop after 20 min, reaching
a value half that of control virus after 60 min. Since this
was not accompanied by a corresponding rise in virus
degradation (only 12% was degraded after 40 min, Figure
3B), we concluded that a large fraction of the internalized
viruses was recycled back to the plasma membrane. This
was consistent with the observation that the tsl virus is
unable to penetrate from endosomes into the cytoplasm
(Miles et al., 1980; Cotten and Weber, 1995; see below).
Despite recycling back to the plasma membrane, an
increasingly large fraction of the tsl virus was degraded,
reaching >60% after 120 min (Figure 3B). Ts degradation
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Fig. 4. Inhibition of fiber dissociation and protein VI precursor
degradation in tsl virus, but not DTT/NEM adenovirus.
[35S]Methionine-labeled tsl or wild-type adenovirus treated or not
with DTT/NEM was endocytosed into KB cells for different times and
the polypeptide composition determined by anti-fiber immunoprecipita-
tions and SDS-PAGE and autoradiography (A: tsl virus). The amount
of hexon co-precipitated with fiber was quantitated by densitometry
and expressed as a percentage of co-precipitated hexon at time 0 (B).
included all the labeled capsid proteins (not shown), but
was significantly reduced if cells were pre-treated with
the lysosomal protease inhibitor leupeptin, a membrane-
impermeable agent that enters endosomes and lysosomes
by fluid phase endocytosis and serves as an effective
inhibitor of proteases in these compartments (Seglen et al.,
1979). The data supported the notion that ts 1 was degraded
in endosomes and/or lysosomes. In contrast, the wild-type
and DTT/NEM viruses were saved from recycling and
degradation perhaps by their efficient penetration into the
cytoplasm. The integrin receptors that adenovirus uses are
known to undergo endocytosis (Felding-Habermann and
Cheresh, 1993; Panetti and McKeown-Longo, 1993;
Shakibaei et al., 1993; Diamond and Springer, 1994).
Aside from this recycling phenomenon with ts 1 virus,
we thus found that the early interactions during entry were
normal. The activity of the L3/p23 protease was apparently
not essential for virus binding to cells nor endocytosis via
integrin receptors.
Fiber shedding and penetration into the cytoplasm
We have shown previously that prior to virus penetration
from endosomes into the cytoplasm the fibers are quantitat-
ively released, and that this release does not require a low
pH in the endosomal compartment (Greber et al., 1993).
Using a co-precipitation assay, we found that the protease-
free tsl particles did not release their fibers quantitatively
(Figure 4). After 120 min of warming, 80% of the
non-degraded hexon was still precipitable with anti-fiber
antibodies. In contrast, the DTT/NEM-inactivated viruses
released their fibers as quickly and efficiently as control
virus (Figure 4B). This observation implied that protease
activity as such was not required for fiber shedding. The
poor shedding of fibers from tsl virus was most likely
due to the same cause as failure of the viruses to penetrate:
the incomplete assembly status of capsids in which pre-
cursor proteins are uncleaved (Philipson, 1983; Weber,
1995).
To test whether the DTT/NEM-inactivated viral particles
were able to penetrate into the cytoplasm, we performed
electron microscopy after a 60 min incubation at 37°C
with control virus and DTT/NEM-inactivated virus at high
multiplicity (Figure 5). In both cases, most of the particles
seen were in the cytoplasm, many near the nuclear
envelope and close to the pore complexes. Quantitative
analysis of >200 particles located closer than two virus
diameters from the nuclear envelope in 30-40 different
cells (50-60 micrographs) revealed that, for both viruses,
an average of 4.3 viral particles per micrograph sample
were associated with the nuclear envelope. Of the nuclear
envelope-associated viruses, 29% of control and 21%
of the DTT/NEM viruses were associated with pore
complexes, which contained on average 1.3 mock-treated
viruses and 1.1 DTT/NEM-treated viruses, respectively
(Table I). Since the pore complexes cover only -10% of
the total nuclear envelope in these cells (Gerace and
Burke, 1988), the association was clearly specific.
We concluded that DTT/NEM-inactivated viruses were
able to penetrate into the cytoplasm efficiently, move to
the nuclear envelope and bind to nuclear pore complexes.
Protein VI degradation is inhibited in
protease-defective or -deficient viruses
As already mentioned, protein VI is located inside the
capsid in contact with the DNA (Russell and Precious,
1982; Stewart et al., 1993; Matthews and Russell, 1994).
It is thought to form a bridge between the peripentonal
hexons and the DNA, thus stabilizing the capsid structure.
Our previous studies have shown that, during virus entry,
protein VI is degraded (Greber et al., 1993).
To test whether protein VI is degraded in the absence
of L3/p23 protease activity, [35S]methionine-labeled DTT/
NEM virus and tsl viruses were allowed to be endocytosed
at 37°C for different times and were analyzed by SDS-
PAGE and autoradiography (Figure 6). While ~80% of
the protein VI in control virus was degraded within 2 h,
the protein remained unchanged in tsl virus (Figures 4A
and 6B). In DTT/NEM-inactivated virus, only ~25% of
protein VI was degraded. In reduced viruses that had been
alkylated with IAA or DTDP, the protein VI behaved
similarly to the DTT/NEM-treated virus, whereas in virus
preparations treated with DTT or NEM alone protein VI
was degraded with efficiencies similar to control virus
(Figure 6B). Degradation was not inhibited by addition of
a serine protease inhibitor, phenylmethylsulfonyl fluoride
(PMSF), or inhibitors of trypsin and chymotrypsin-like
enzymes, L- 1 -tosylamido-2-phenylethyl chloromethyl
ketone (TPCK) and 1-chloro-3-tosylamido-7-amino-2-
heptanone (TLCK) (data not shown). This suggested that
endosomal or lysosomal proteases were not involved.
The time course of protein VI degradation for the
control virus showed that half of protein VI was degraded
already within 20 min of internalization, i.e. shortly after
virus penetration into the cytosol, which occurs with a
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Fig. 5. Localization of incoming DTT/NEM adenovirus to the nuclear pore complex. Mock- or DTT/NEM-treated adenovirus was internalized into
KB cells at 1000 p.f.u. per cell for 60 min at 370C [(A) Mock, (B) DTTINEM)]. Samples were fixed, embedded in Epon and processed for thin
section electron microscopy. Pore complex-associated virus is labeled with an arrowhead. Bar = km.
half-time of 15 min (Greber et al., 1993). The endosomal
protease inhibitor leupeptin had no effect on the degrada-
tion. Monensin, a carboxylic ionophore that increases
vacuolar pH and inhibits acid hydrolases, also had no effect
(Figure 6). These findings suggested that the degradation of
protein VI was independent of low pH and of endosomal
and lysosomal proteases. Also, since monensin blocks
virus penetration into the cytosol (Seth et at., 1984;
Yoshimura, 1985), these results demonstrated that the
degradation could occur while the virus was inside the
1770
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Table I. Pore complex association of incoming DTT/NEM- and mock-treated adenovirus
Micrographs Virus at NE Virus per NE Virus at NPC Virus per NPC Virus at NPC/NE
sample (mean) (mean) (meanX 100, SE)
Mock-Ade 54 240 4.3 67 1.3 28.9 + 4.2%
DTT/NEM-Ade 61 267 4.3 68 1.1 21.4 + 2.8%
Mock- or DTT/NEM-treated adenovirus was incubated with KB cells at 1000 p.f.u. per cells for 60 min at 370C and samples were processed for thin
section electron microscopy. Two hundred and forty mock- and 267 DTT/NEM-treated viral particles closer than two virus diameters at the nuclear
envelope (NE) were counted blindly in 34 and 37 different cells, respectively. The mean number of mock and DTT/NEM-treated viruses per nuclear
envelope sample was 4.3. Sixty-seven mock- and 68 DTT/NEM-treated viruses were unequivocally associated with nuclear pore complexes (NPCs).
The average number of particles per pore complex was 1.3 mock- and 1.1 DTT/NEM-treated viruses. The mean percentage pore complex-associated
virus per nuclear envelope was 28.9% mock- and 21.4 % DTT/NEM-treated viruses. Standard errors (SE) were derived from 54 mock- and 61 DTT/
NEM-treated virus micrographs.
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Fig. 6. Protein VI degradation in incoming DTT/NEM-treated
adenovirus is inhibited. DT[/NEM-, D1T-, NEM- or mock-treated
[35S]methionine-labeled wild-type adenovirus or tsl virus was bound
and endocytosed into KB cells in the presence or absence of
monensin, RGD or irrelevant peptides (RGES) for different times.
TCA-precipitated cell extracts were analyzed by SDS-PAGE and
autoradiography (A) and the amount of protein VI determined by
densitometry normalized to the amount of hexon present in each
sample (B).
endocytic vacuoles, i.e. the virus did not have to reach
the cytosol for the degradation to occur.
However, the endosomal and lysosomal proteases were
apparently, at least in part, responsible for another degrada-
tion step, the partial degradation of incoming hexon which
normally begins much later, between 40 and 150 min after
internalization (Figure 6) (see also Greber et al., 1993).
Unlike protein VI, hexon degradation was slowed down
markedly by both leupeptin and monensin. Hexon of the
ts virus was degraded even though the virus does not
reach the cytoplasm, suggesting that hexon degradation
occurs in the endocytic pathway (Figure 4A). In contrast,
the degradation of hexon in the DTT/NEM-treated virus
was reduced compared with the untreated or NEM alone-
treated virus, supporting the notion that the DTT/NEM-
treated virus was not degraded by endosomal/lysosomal
enzymes.
Binding to integrin receptors is needed to trigger
degradation
To test whether receptor binding was a prerequisite for
protein VI degradation, wild-type virus was bound to KB
cells in the cold, whereafter the cells were warmed to
37°C in the presence of RGD peptides which prevent virus
attachment to the integrin receptors and virus endocytosis
(Wickham et al., 1993). Protein VI degradation was clearly
inhibited by the RGD peptides, but not by control peptides
(Figure 6). Thus, degradation of protein VI was dependent
on changes either in the virus itself induced by the
binding to integrins or by the subsequent receptor-mediated
endocytosis into endosomes.
Since it was possible that endocytosis exposed the virus
to a more reducing milieu inside the endosomes, we tried
to bypass the RGD peptide block by addition of 5 mM
DTT or 10 mM glutathione. This did not lead to protein
VI degradation (data not shown), indicating that attachment
of the virus to the cell via the fibers alone, even under
reducing conditions, did not activate protein VI degrada-
tion. Attachment via the penton base proteins to the
integrin receptor may therefore induce a necessary change
in the capsid structure without which protein VI degrada-
tion cannot occur. It might be significant that protein VI
is located just underneath the penton structure at the
peripentonal hexons.
Disassembly and nuclear import are inhibited in
protease-defective virus
Up to the point of virus binding to the nuclear pore
complex, our results had indicated no difference between
DTT/NEM and control virus entry except that in the DTT/
NEM virus protein VI did not get digested.
To analyze whether the final disassembly process was
also normal for this inactivated virus, we monitored
capsid uncoating by immunofluorescence and confocal
microscopy. We took advantage of the observation that
anti-capsid or anti-core antibodies often bind more effici-
ently to disassembled capsid proteins than to intact capsids
(Martin and Helenius, 1991; Singh and Helenius, 1992).
The major increase in fluorescence intensity can therefore
be used to monitor the uncoating process.
We used two different antibodies, a non-neutralizing
anti-hexon antibody and an anti-protein VII-specific anti-
body (Prage and Pettersson, 1971; Baum et al., 1972).
The hexon antibodies gave only faint labeling of surface-
bound mock-, NEM- or DTT/NEM-treated viruses (images
not shown, for quantitated data see Figure 7B). However,
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Fig. 7. DTT/NEM-treated adenovirus is uncoating-defective. (A) Mock- (a-d), NEM- (e-h) or DTT/NEM-treated adenovirus (i-I) was bound in the
cold and endocytosed into HeLa cells for 150 min at 37°C. Cells were processed for double labeling indirect immunofluorescence microscopy using
rabbit anti-hexon (a, e and i), rabbit anti-protein VII (b, f and j; c, g and k) and mouse anti-pore complex antibodies (d, h and 1) followed by
secondary goat anti-rabbit-Texas red and goat anti-mouse-fluorescein antibodies, respectively. Photographs were taken using a regular fluorescence
microscope (a, e and i; b, f and j) and a confocal microscope (c, g and k; d, h and 1), respectively. (B) Mock-treated adenovirus was bound and
internalized into HeLa cells for the indicated times at 37°C. Cells were fixed and processed for indirect immunofluorescence confocal microscopy
using anti-hexon and anti-protein VII antibodies, respectively. The average pixel intensity was determined in optical sections across the cell centers
and plotted as mean values together with the standard deviations derived from 20-37 different cells per time point. (C) Mock-, NEM- or DTT/NEM-
treated adenovirus labeled or not labeled with [3H]thymidine was internalized into HeLa cells for 150 min at 37°C. Cells were either analyzed for
fluorescence intensity as described above or hexon-associated viral DNA was determined by co-immunoprecipitation with anti-hexon antibodies as
described (Greber et al., 1993). Between 30 and 40% of the total cell-associated 3H-labeled DNA from wild-type or NEM-treated virus and -20% of
the DNA from DTT/NEM-treated virus was precipitated with the anti-hexon antibody. The data were normalized to the signal from mock-treated
virus (100%). n represents the number of cells analyzed by fluorescence and the number of independent DNA-anti-hexon co-precipitation
experiments, respectively.
after 150 min of infection with either mock- or NEM
alone-treated virus, the anti-hexon antibody gave intense
and predominantly cytoplasmic punctuate labeling (Figure
7A). A small amount of labeling was also observed inside
the nucleus. Quantification of the hexon signal in the
cytoplasm revealed a rapid increase starting after a lag of
~40 min (Figure 7B). This time course was consistent
with biochemical analysis of DNA dissociation from
hexons (Greber et al., 1993), and with the disappearance
of visible capsids by thin section electron microscopy. The
data would suggest that -50% of the particles disassembled
within 50 min of infection.
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In contrast to native virus, the DTT/NEM-inactivated
virus did not show a dramatic increase in hexon fluores-
cence (Figure 7A and C). The amount of fluorescence
after 150 min of warming was only 20% of that observed
for native virus. The lack of an increase in signal was not
due to diminished reactivity of the alkylated antigen with
the antibodies, since the antibodies bound strongly to both
alkylated and reduced/alkylated hexon on Western blots
(data not shown).
The result thus indicated that the defect in the DTT/
NEM-treated virus manifested itself at the level of final
capsid disassembly. While the viruses were able to bind
to the nuclear pore complexes, they did not disassemble
so that the hexons would become more accessible to
antibodies.
This conclusion was supported by the results obtained
with the anti-protein VII antibody. Protein VII is one of
the structural proteins associated directly with the viral
DNA (Horwitz, 1990). No staining of cell surface-bound
or of cytosolic virus was ever seen with this antibody,
consistent with the antigen being inaccessible inside the
intact viruses and cytosolic capsids. However, after a
40 min lag, the antibody showed relatively strong fluores-
cence in the nucleus (Figure 7A and B). The staining was
present in a discrete punctate and sometimes also more
diffuse pattern. Double labeling confocal fluorescence
microscopy with the nuclear pore complex-specific anti-
body RLI as a marker (Snow et al., 1987) confirmed that
the protein VII entered the nucleus, and localized in
structures near the periphery of the nuclear envelope
(Figure 7A). The apparent half-time of protein VII arrival
in the nucleus was delayed compared with capsid disassem-
bly, suggesting that full exposure of protein VII to the
antibody occurred later.
When DTT/NEM virus was used, practically no protein
VII staining was detected in the nucleus nor anywhere
else in the cell (Figure 7). Apparently, protein VII was
not released from the virus nor transported into the nucleus
under these conditions.
We have described previously a biochemical assay for
virus disassembly based on co-precipitation of viral DNA
with hexons (Greber et al., 1993). This assay showed
that ~80% of incoming [3H]thymidine-labeled adenovirus
DNA dissociated from the hexons within 150 min of
warming (Figure 7C). A similar result was obtained for
viruses treated with NEM alone. When we used DTT/
NEM-inactivated virus in this assay, only 10-15% of the
DNA was released from the hexon after 150 min of
infection (Figure 7C). In the presence of RGD peptides, no
dissociation ofDNA from hexon was detected (not shown).
Taken together, these results indicated that the DTT/
NEM-treated virus, in which the viral protease was in-
activated and protein VI was not digested, was unable to
undergo the final disassembly step that normally occurs
when the virus binds to the nuclear pore complex. Since
the DNA did not dissociate from the hexons, and since
protein VII, a DNA binding protein, did not get exposed,
it was likely that the DNA remained associated with the
capsids in the cytosol. The apparent reason for this effect
was the failure of the viral protease to cleave protein VI
and thereby liberate the DNA from its association with
the capsid.
Discussion
When viruses enter a host cell, they receive signals that
activate their uncoating program. These may involve
interactions with surface receptors, exposure to low pH
in endosomes, association with intracellular factors or
other changes in the immediate environment of the virus
(see Greber et al., 1994). In the case of adenovirus, a
series of different signals is needed for the transport of
the incoming virus from the plasma membrane to the
nucleus. The signals include the interaction of the penton
base with the integrin receptor which leads to endocytosis
and fiber dissociation, low pH-activated membrane lysis
in the early endosome, and association with the nuclear
pore complex. Our data now suggest that for capsid
dissociation and DNA release the structural protein VI
has to be degraded by the viral L3/p23 protease, dormant
in the extracellular virus. Two separate signals are both
needed to trigger this event, virus interaction with integrin
receptors and re-entry into a reducing environment.
About 10 copies of the L3/p23 protease are present in
each viral particle (Anderson, 1990). They are located in
the central cavity and bound to the DNA (Everitt and
Ingleman, 1984; Mangel et al., 1993) and require specific
sequence motifs in the substrate proteins (Webster et al.,
1994). Protease isolated from adenovirus has no measur-
able activity unless first treated by urea and reducing
agents (Webster and Kemp, 1993; Rancourt et al., 1995). It
is clear that the enzyme requires free thiols for its activity.
While proteolytic degradation events have rarely been
described during virus entry (Greber et al., 1994), viral
proteases are known to play a crucial role during the
assembly of numerous viruses (see Hellen and Wimmer,
1992). For adenovirus, the role of a protease during virus
assembly is illustrated by the tsl mutant which lacks L3/
p23 protease (Weber, 1976; Rancourt et al., 1995). As a
result, several of the structural proteins remain unpro-
cessed, and the released viruses have an immature surface
structure and remain non-infectious (Hannan et al., 1983).
We found that while the particles bound to cell surface
receptors and were endocytosed, they failed to shed their
fibers subsequently. They ended up in a futile recycling
circuit between endosomes and the plasma membrane.
Moreover, the ts 1 particles did not respond properly to
low pH and failed to penetrate from the endosomes into
the cytosol (Cotten and Weber, 1995; Greber, unpublished
data). Importantly, protein VI remained undegraded.
To uncouple the role of the L3/p23 protease during
assembly from a possible role during disassembly, we
treated isolated wild-type virus with the L3/p23 inhibitor
NEM. While it is clear that NEM alkylates cysteines in
other capsid proteins besides the protease (see also Figure
2A), our subsequent data argue that alkylation of the
reduced virus had a selective effect on uncoating and
nuclear import, but did not affect the function of capsid
proteins needed for cell binding, endocytosis, penetration,
transport to the nucleus and localization to the pore
complex. Consistently, DTT reduction of the virus causes
no conformational changes in capsid proteins, except in
the protease (Anderson et al., 1973; Figure 2B). NEM
treatment of native, non-reduced virus, on the other hand,
had no effect on infectivity, uncoating and nuclear import,
and correlated with the absence of alkylation of the
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Fig. 8. Cell entry and uncoating of protease-defective adenoviruses. Protease-lacking, incompletely assembled ts I and fully assembled DTT/NEM-
protease inactivated adenovirus bind to cells and endocytose via integrins with efficiencies and kinetics similar to wild-type virus. In contrast to
wild-type and protease-inactivated virus, tsl virus does not shed fibers and penetrate from endosome into the cytoplasm, but is recycled to the
plasma membrane. Binding of wild-type virus to integrins together with reducing agents in the cytoplasm or endosomes (X-SH) triggers the L3/p23
protease-dependent degradation of the internal capsid protein VI (curved arrows) and enables the capsid to disassemble completely at the nuclear
membrane and import its DNA into the nucleus. Protease-inactivated virus, in contrast, does not degrade protein VI. It penetrates into the cytoplasm,
is transported to the nuclear envelope and pore complexes like wild-type virus, but is unable to disassemble and import its DNA-associated protein
VII into the nucleus.
L3/p23 protease. Interestingly, DTT reduction was not
absolutely necessary to make the virus susceptible to
NEM, since virus infectivity was reduced 2- to 3-fold
more effectively if virus was alkylated in the reducing
milieu of the infected cell before release into the oxidizing
medium. It is possible that protease in the intracellular
virus or the cysteine-containing activating peptide is more
susceptible to NEM than protease or peptide of DTT-
treated isolated virus. Protease from the latter virus was
only partially reduced with DTT (see Figure 2B, lane 7).
Lastly, another L3/p23 protease inhibitor, copper chloride,
recently was reported effectively to block adenovirus-
mediated delivery of carrier genes into the nucleus (Cotten
and Weber, 1995). Where the block occurred in these
experiments was, however, not investigated.
Our results suggest that the L3/p23 protease is
responsible for the degradation of the capsid protein VI,
a capsid-stabilizing factor. According to image reconstruc-
tion analysis of isolated virus, protein VI is located entirely
inside the capsid, and is, therefore, poorly accessible to
cellular proteases (Stewart et al., 1993). A variety of
inhibitors of proteases of the endocytic pathway, such as
leupeptin and monensin, had no effect on degradation of
protein VI, whereas they inhibited the partial degradation
of hexon protein later in infection.
Moreover, our experiments with native, reduced and
alkylated virus show that a viral activity was needed for
the degradation of protein VI and for the subsequent
disassembly of the capsids at the nuclear membrane. Since
protein VI has no cysteines and was not labeled by
[3H]NEM, it seems clear that the effects of these sulfhydryl
reagents were not on the substrate. L3/p23 was, in fact,
strongly labeled by [3H]NEM after prior DTT reduction,
correlating with the capacity of the alkylating agent to
inhibit protein VI digestion.
That the cysteine protease L3/p23 is involved in the
degradation of protein VI is supported by several indirect
observations. First, under certain conditions, the L3/p23
protease can cleave degenerate consensus sites (unpub-
lished observations). One such site in protein VI is PEGR-
G, located between residues 94 and 95. Second, a major
fraction of recombinant protein VI precursor is degraded
completely when incubated with recombinant protease in
the presence of the protease-activating C-terminal peptide
from protein VI (pVIc-peptide) (Matthews and Russell,
1995). Third, reducing agents are required for protease
activity in vitro, presumably for disulfide interchange with
the disulfide-linked dimer of the activating pVIc-peptide
(Webster et al., 1994). Finally, the reduced but not
the oxidized protease can be inactivated completely by
alkylating agents in vitro, suggesting that the catalytically
active cysteine is accessible for modification and catalysis
(Bhatti and Weber, 1979; Webster et al., 1989). Either
the active site cysteine or another absolutely conserved
cysteine residue at position 122 or 104, which is thought
to form a disulfide bond with the activating pVIc-peptide,
could be modified with the alkylating agent, destroying
protease activity (Grierson et al., 1994; Rancourt et al.,
1994).
It is interesting that re-entry into a reducing environment
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can serve as a cue for virus uncoating. Although the block
in uncoating caused by the failure of protein VI degradation
in the DTT/NEM-treated virus is manifested only at the
last step in the uncoating program, the degradation of the
protein normally occurs much earlier. Degradation occurs
already at the time of endocytosis and penetration from
endosomes into the cytosol. The lack of monensin inhibi-
tion indicates that L3/p23 can be activated, and protein VI
can be digested, within endocytic vacuoles, a compartment
which is thought to contain a reducing milieu causing
disulfide bond reduction (Collins et al., 1991; Pisoni et al.,
1995). However, it is likely that during the normal infection
most of the degradation occurs shortly after the virus
reaches the cytosol (Greber et al., 1993). Protein VI
degradation does not require low pH, which is consistent
with the neutral pH optimum previously reported for L3/
p23 (Bhatti and Weber, 1979; Webster et al., 1989).
Another factor needed for protease reactivation was
the RGD-dependent interaction of the penton base with
integrin receptors. Integrins mediate virus endocytosis and
are a determinant for membrane penetration at low pH
(Bai et al., 1993; Wickham et al., 1993, 1994; Goldman
and Wilson, 1995). We think that the binding of penton
base to integrins induces a conformational change in the
vertex region of the capsid, exposing hidden protease
cleavage sites in protein VI.
Taken together, the data suggest the following scenario
(see also Figure 8). When newly assembled viruses are
released from the nucleus of the lysing host cell, the L3/
p23 proteases encounter the oxidizing extracellular milieu.
The enzymes are inactivated by the formation of intrachain
disulfides. When the viruses bind to a new host cell, the
integrin receptors on the cell surface associate with the
penton base proteins. This interaction leads not only to
the release of the fibers but also to a conformational
change in the penton complexes such that previously
hidden protease L3/p23 cleavage sites in the penton-
associated protein VI become exposed. When, moments
later, the virus enters a more reducing environment in the
endosome or the cytosol, the inactivating disulfide bond
is reduced, and the protease is re-activated. This leads to
degradation of protein VI. Since protein VI is bound to
the DNA and to the peripentonal hexons (Russell and
Precious, 1982; Stewart et al., 1993; Matthews and Russell,
1994), the cleavage results in the release of the anchored
DNA from the inside wall of the capsid. Later, when the
virus undergoes additional changes at the nuclear pore
complex, the DNA is free to escape.
Adenoviruses have evolved a finely tuned disassembly
program which allows them to deliver their genes into the
nuclei of non-dividing cells. To develop efficient gene
delivery and expression systems based on the virus para-
digm, more detailed information about uncoating and
intracellular transport of the incoming viral particles is
needed (Mulligan, 1993; Greber et al., 1994; Michael and
Curiel, 1994). The crucial points illustrated by our results
are the close interplay between cellular and viral functions
and the complexity of the disassembly program involved
in targeting and liberating the genome for transcription
and replication in the nucleus.
Materials and methods
Virus, cells and antibodies
Adenovirus type 2 (wild-type, from Dr E.White, The State University
of New Jersey) and H2tsl adenovirus (tsl) were grown in HeLa cells
and purified by CsCl density gradient centrifugation and plaque-assayed
as described (Weber, 1976; Greber et al., 1993). Monolayers of A549,
HeLa and KB cells (obtained from American Type Culture Collection,
Rockville, MD) were maintained as described (Greber et al., 1993).
[35S]Methionine- and [3H]thymidine-labeled wild-type adenovirus was
prepared as described (Greber et al., 1993). [35S]Methionine-labeled tsl
virus was prepared by infecting HeLa cells for 12 h at 39°C with -5
p.f.u./cell of a p2 stock grown at 32'C. Endogenous methionine was
depleted for 30 min in methionine-free MEM containing 5% fetal bovine
serum, and viral proteins were labeled for 9 h at 39'C with 1 mCi of
TRAN35S-Label (1000 Ci/mmol, ICN Biomedicals Inc., Irvine, CA) per
7 cm dish, followed by a chase with excess cold methionine for 48 h.
Virus was released from cells by repeated freeze-thawing and freon
extraction and purified by CsCl gradients as described (Greber et al.,
1993).
Rabbit antisera against hexon (R70), fiber (R72) and protein VII were
generous gifts of Dr M.Horwitz (Albert Einstein University, New York)
and Dr U.Pettersson (University of Uppsala, Sweden) (Prage and
Pettersson, 1971; Baum et al., 1972). IgG fractions were obtained
by pH 3.0 elution from protein G-Sepharose as described (Greber
et al., 1993).
Virus inactivation
Intracellular adenovirus (62 h post-infection) was treated with 10 mM
NEM for 20 min on ice in phosphate-buffered saline (PBS), extracted
by freon, purified by CsCI density gradient centrifugation, dialyzed and
tested for infectivity by plaque assays as described (Greber et al., 1993).
Extracellular virus, purified from HeLa cells by freon extraction and
CsCl density gradient centrifugation (0.5 mg/ml protein as determined
by the BCA assay, Pierce, Rockford, IL), was dialyzed in a Collodion
membrane bag (Schleicher and Schuell, Keene, NH) against 0.02 M
Tris, 0.15 M NaCI, pH 7.5 and reduced with 10 mM DTT in the presence
of 1 mM EDTA at 4°C for 60 min. DTT and EDTA were removed by
dialysis against 0.02 M Tris, 0.15 M NaCI, pH 7.5 at 4°C for 30 min.
Sulfhydryl groups were alkylated with 10 mM NEM, IAA or DTDP, or
oxidized with diamide (20 mM) (all reagents from Sigma, St Louis,
MO) or with 0.1 mCi [3H]NEM (44.1 Ci/mmol, 1 mCi/ml, NEN-Du
Pont, Wilmington, DE) at 4°C for 20 min. The inhibitors were removed
by dialysis against 0.01 M Tris, 0.15 M NaCl, pH 7.5 at 4'C for 2 h
and treated with 10 mM DTT followed by dialysis, or virus was
incubated with cells or analyzed by SDS-PAGE. Mock-treated virus
was prepared in parallel by incubation of virus without inhibitors.
Infectivity was tested by plaque assays on A549 cells.
Virus entry into cells
Mock- or inhibitor-treated virus was bound to cells and internalized as
described (Greber et al., 1993). Internalization was measured by trypsin
digestion of surface-bound adenovirus hexon protein in the cold in the
presence or absence of GRGDSP peptides (3 mM, Telios Pharmaceuticals,
San Diego, CA) or control peptides (e.g. CGYGPKNKRKVED, Yale,
CT, Peptide Synthesis Facility, or RGES peptides, Sigma, St Louis, MO)
(Greber et al., 1993). Monensin (10 ,uM, Sigma, St Louis, MO) was
added to cells at 37°C, 30 min prior to infection in slightly alkaline
growth medium. Overall degradation of incoming [35S]methionine-
labeled virus was determined by TCA precipitation of cell lysates and
liquid scintillation counting of TCA-soluble and -insoluble material.
Incoming [35S]methionine- or [3H]thymidine-labeled wild-type adeno-
virus or ts 1 virus was immunoprecipitated with anti-fiber and anti-
hexon antibodies, respectively, and analyzed by SDS-PAGE or liquid
scintillation counting as described (Greber et al., 1993). In brief, cells
were lysed in 0.5% Empigen BB (Calbiochem, San Diego, CA) in MNT
buffer [20 mM 2-(N-morpholino)ethanesulfonic acid (MES), 30 mM
Tris, pH 7.5, 100 mM NaCI] containing 0.1 mM EDTA, 0.5 mM PMSF
and benzamidine, and 10 ,ug/ml of chymostatin, leupeptin, antipain,
pepstatin, TPCK and TLCK. Lysates were cleared by centrifugation and
either immunoprecipitated with anti-fiber R72 antibodies and fixed
Staphylococcus aureus bacteria (Zymed Laboratories Inc, San Francisco,
CA) or precipitated with 15% TCA and analyzed by SDS-PAGE.
SDS-PAGE and Western blotting
Virus or virus/cell extracts were concentrated by TCA precipitation,
washed in ice-cold acetone (90%, 10% 10 mM HCI), dried and dissolved
in SDS sample buffer (Greber et al., 1993). Reduced (20 mM DTT) or
unreduced samples were boiled at 95'C for 3 min and separated on
12.5% polyacrylamide gels in SDS (Laemmli, 1970). Fluorography was
done by fixing the gels in 20% methanol-PBS for 30 min on an orbital
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shaker, and incubation with AmplifyTM (Amersham, Arlington Heights,
IL) for 45 min.
Proteins from SDS gels were electrotransferred onto nitrocellulose
membrane (Schleicher and Schuell, Keene, NH) using a semi-dry blotter
(Millipore, Bedford, MA) and labeled with anti-protease antiserum
(1:100) (Rancourt et al., 1994). Bound IgG was identified by ECL
(Amersham, Arlington Heights, IL) using goat anti-rabbit IgG coupled
to horseradish peroxidase (Sigma, St Louis, MO).
Indirect immunofluorescence and laser scanning confocal
microscopy
Inhibitor- or mock-treated wild-type adenovirus (200 p.f.u. per cell) was
bound to HeLa cells on glass coverslips at 4°C for 2 h. Unbound virus
was washed off and warm MEM-BSA was added and the cells incubated
for different times at 37°C. Cells were washed with cold PBS, fixed
with 3% paraformaldehyde for 10 min, quenched with 25 mM ammonium
chloride in PBS, pH 7.4, for 5 min, permeabilized with 0.5% Triton X-
100 in PBS for 5 min, washed in PBS and incubated with anti-hexon
R70 IgGs (10 gg/ml) or anti-protein VII IgGs (10 gg/ml) for 1 h at 4°C
in the presence or absence of the anti-pore complex antibodies RL1 [5
gg/ml mouse IgM (Snow et al., 1987)]. Viral antibodies were pre-
adsorbed against fixed and Triton X-100-extracted uninfected HeLa cells
at 10 gg/ml IgG for 12 h at 4°C before use. Primary antibodies were
visualized with goat anti-rabbit IgG conjugated to Texas red and goat
anti-mouse IgM conjugated to fluorescein, respectively, at 10 ,ug/ml
(Zymed Laboratories, San Francisco, CA). Coverslips were mounted in
Mowiol containing 2% 1,4-diazobicyclo-[2,2,2]-octane (Harlow and
Lane, 1988) and analyzed on a Bio-Rad MRC-600 confocal imaging
system equipped with a Zeiss Axiovert 10 microscope and a 63X
Planapochromat lens. Confocal settings were: 0.3 mW laser power,
Kalman filters, I s/frame, 8 frames/image. The photomultiplier gain was
set at maximum and the confocal aperture was adjusted to 5, yielding
optical slices of -0.7 ,um thickness. Images of an area of 200X280 gm2 and
a raster size of 512X756 pixels were taken through the center of the
cells, collected through the rhodamine and fluorescein channels in dual
channel mode and photographed on Kodak TMAX 400 film (Eastman
Kodak Co., Rochester, NY). For fluorescence quantification, the average
fluorescence intensity (pixel units) across the cytoplasm and the nucleus
of 13-40 randomly chosen cells was determined for hexon epitopes and
protein VII epitopes, respectively, using the Bio-Rad area software.
Where indicated, photographs were also taken on TMAX 400 film using
an Axiophot microscope (Carl Zeiss Inc., Thomwood, NY) equipped
with a 63 X Planapochromat lens.
Electron microscopy and stereology
Pellets of infected cells were fixed in 2.5% glutaraldehyde buffered in
100 mM sodium cacodylate, pH 7.4, post-fixed in 2% osmium tetroxide
in the same buffer and stained en bloc with 1% uranyl acetate in 50 mM
sodium maleate, pH 5.2 (Griffiths, 1993). The pellets were dehydrated in
ethanol, embedded in Epon and sectioned. The thin sections were
mounted on Formvar/carbon-coated specimen grids, contrasted with 3%
aqueous uranyl acetate and lead citrate, and examined in a Phillips 410
transmission electron microscope operating at 80 kV. Micrographs were
taken from randomly sampled cells, and the numbers of viruses localized
to the nuclear envelope and nuclear pore complexes were counted. For
association with the nuclear envelope, only viral particles that were
closer than two virus diameters were scored. For association with the
nuclear pore complex, only those events were counted where unequivocal
identification of the pore complex was possible.
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